世界の筋萎縮性側索硬化症（ALS）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Amyotrophic Lateral Sclerosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0303 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、理学療法、言語療法、その他）、用途別市場規模（病院、専門センター、研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋萎縮性側索硬化症（ALS）治療の市場動向 ・企業の競争状況、市場シェア ・筋萎縮性側索硬化症（ALS）治療の種類別市場規模（薬物療法、理学療法、言語療法、その他） ・筋萎縮性側索硬化症（ALS）治療の用途別市場規模（病院、専門センター、研究センター、その他） ・筋萎縮性側索硬化症（ALS）治療の北米市場規模2016-2027（アメリカ、カナダ） ・筋萎縮性側索硬化症（ALS）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋萎縮性側索硬化症（ALS）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋萎縮性側索硬化症（ALS）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋萎縮性側索硬化症（ALS）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Roche、Biogen、Mitsubishi Tanabe Pharma、GNT Pharma、Synthetic Biologics、Amkor Pharma、ViroMed、Brainstorm Therapeutics、Bausch Health） ・結論

Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.
The North American amyotrophic lateral sclerosis market is a growing market. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. The increasing prevalence of ALS affected population, along with the rising older population is likely to drive the market.

Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis Treatment Market
The global Amyotrophic Lateral Sclerosis Treatment market size is projected to reach US$ 439.8 million by 2026, from US$ 274.3 million in 2019, at a CAGR of 6.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amyotrophic Lateral Sclerosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amyotrophic Lateral Sclerosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amyotrophic Lateral Sclerosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amyotrophic Lateral Sclerosis Treatment market.

Global Amyotrophic Lateral Sclerosis Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medication
Physical Therapy
Speech Therapy
Others

Segment by Application
Hospitals
Specialty Centers
Research Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Roche
Biogen
Mitsubishi Tanabe Pharma
GNT Pharma
Synthetic Biologics
Amkor Pharma
ViroMed
Brainstorm Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Physical Therapy
1.2.4 Speech Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Centers
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Perspective (2016-2027)
2.2 Amyotrophic Lateral Sclerosis Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amyotrophic Lateral Sclerosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Amyotrophic Lateral Sclerosis Treatment Industry Dynamic
2.3.1 Amyotrophic Lateral Sclerosis Treatment Market Trends
2.3.2 Amyotrophic Lateral Sclerosis Treatment Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis Treatment Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis Treatment Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Amyotrophic Lateral Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Treatment Revenue
3.4 Global Amyotrophic Lateral Sclerosis Treatment Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Treatment Revenue in 2020
3.5 Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Area Served
3.6 Key Players Amyotrophic Lateral Sclerosis Treatment Product Solution and Service
3.7 Date of Enter into Amyotrophic Lateral Sclerosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis Treatment Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Type (2022-2027)

5 Amyotrophic Lateral Sclerosis Treatment Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Amyotrophic Lateral Sclerosis Treatment Market Size (2016-2027)
6.2 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type
6.2.1 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2027)
6.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application
6.3.1 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2027)
6.4 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country
6.4.1 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Treatment Market Size (2016-2027)
7.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type
7.2.1 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2027)
7.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application
7.3.1 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2027)
7.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country
7.4.1 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Type
8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Application
8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region
8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size (2016-2027)
9.2 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Type
9.2.1 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Application
9.3.1 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Country
9.4.1 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type
10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application
10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country
10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Introduction
11.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Introduction
11.2.4 Roche Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Introduction
11.3.4 Biogen Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.3.5 Biogen Recent Development
11.4 Mitsubishi Tanabe Pharma
11.4.1 Mitsubishi Tanabe Pharma Company Details
11.4.2 Mitsubishi Tanabe Pharma Business Overview
11.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
11.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.4.5 Mitsubishi Tanabe Pharma Recent Development
11.5 GNT Pharma
11.5.1 GNT Pharma Company Details
11.5.2 GNT Pharma Business Overview
11.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
11.5.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.5.5 GNT Pharma Recent Development
11.6 Synthetic Biologics
11.6.1 Synthetic Biologics Company Details
11.6.2 Synthetic Biologics Business Overview
11.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Introduction
11.6.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.6.5 Synthetic Biologics Recent Development
11.7 Amkor Pharma
11.7.1 Amkor Pharma Company Details
11.7.2 Amkor Pharma Business Overview
11.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
11.7.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.7.5 Amkor Pharma Recent Development
11.8 ViroMed
11.8.1 ViroMed Company Details
11.8.2 ViroMed Business Overview
11.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Introduction
11.8.4 ViroMed Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.8.5 ViroMed Recent Development
11.9 Brainstorm Therapeutics
11.9.1 Brainstorm Therapeutics Company Details
11.9.2 Brainstorm Therapeutics Business Overview
11.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Introduction
11.9.4 Brainstorm Therapeutics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.9.5 Brainstorm Therapeutics Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Details
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Introduction
11.10.4 Bausch Health Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
11.10.5 Bausch Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Physical Therapy
Table 4. Key Players of Speech Therapy
Table 5. Key Players of Others
Table 6. Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions (2016-2021)
Table 10. Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions (2022-2027)
Table 12. Amyotrophic Lateral Sclerosis Treatment Market Trends
Table 13. Amyotrophic Lateral Sclerosis Treatment Market Drivers
Table 14. Amyotrophic Lateral Sclerosis Treatment Market Challenges
Table 15. Amyotrophic Lateral Sclerosis Treatment Market Restraints
Table 16. Global Amyotrophic Lateral Sclerosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Amyotrophic Lateral Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Treatment as of 2020)
Table 19. Ranking of Global Top Amyotrophic Lateral Sclerosis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Amyotrophic Lateral Sclerosis Treatment Product Solution and Service
Table 23. Date of Enter into Amyotrophic Lateral Sclerosis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Amyotrophic Lateral Sclerosis Treatment Product
Table 66. Sanofi Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Amyotrophic Lateral Sclerosis Treatment Product
Table 71. Roche Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Biogen Company Details
Table 74. Biogen Business Overview
Table 75. Biogen Amyotrophic Lateral Sclerosis Treatment Product
Table 76. Biogen Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 77. Biogen Recent Development
Table 78. Mitsubishi Tanabe Pharma Company Details
Table 79. Mitsubishi Tanabe Pharma Business Overview
Table 80. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product
Table 81. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 82. Mitsubishi Tanabe Pharma Recent Development
Table 83. GNT Pharma Company Details
Table 84. GNT Pharma Business Overview
Table 85. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product
Table 86. GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 87. GNT Pharma Recent Development
Table 88. Synthetic Biologics Company Details
Table 89. Synthetic Biologics Business Overview
Table 90. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product
Table 91. Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 92. Synthetic Biologics Recent Development
Table 93. Amkor Pharma Company Details
Table 94. Amkor Pharma Business Overview
Table 95. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product
Table 96. Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 97. Amkor Pharma Recent Development
Table 98. ViroMed Company Details
Table 99. ViroMed Business Overview
Table 100. ViroMed Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 101. ViroMed Recent Development
Table 102. Brainstorm Therapeutics Company Details
Table 103. Brainstorm Therapeutics Business Overview
Table 104. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product
Table 105. Brainstorm Therapeutics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 106. Brainstorm Therapeutics Recent Development
Table 107. Bausch Health Company Details
Table 108. Bausch Health Business Overview
Table 109. Bausch Health Amyotrophic Lateral Sclerosis Treatment Product
Table 110. Bausch Health Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 111. Bausch Health Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Physical Therapy Features
Figure 4. Speech Therapy Features
Figure 5. Others Features
Figure 6. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Specialty Centers Case Studies
Figure 9. Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Treatment Report Years Considered
Figure 12. Global Amyotrophic Lateral Sclerosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Amyotrophic Lateral Sclerosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Players in 2020
Figure 17. Global Top Amyotrophic Lateral Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Treatment Revenue in 2020
Figure 19. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2016-2027)
Figure 23. North America Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2016-2027)
Figure 24. North America Amyotrophic Lateral Sclerosis Treatment Market Share by Country (2016-2027)
Figure 25. United States Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Amyotrophic Lateral Sclerosis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Share by Region (2016-2027)
Figure 41. China Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Amyotrophic Lateral Sclerosis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 62. Biogen Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 63. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 64. GNT Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 65. Synthetic Biologics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 66. Amkor Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 67. ViroMed Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 68. Brainstorm Therapeutics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 69. Bausch Health Revenue Growth Rate in Amyotrophic Lateral Sclerosis Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---